Connect with us
Reig Jofre is the only one that does not follow the upward trend of the Spanish pharmaceutical sector and closes the third quarter with a decrease...
In recent years, Grifols has invested in its innovation infrastructure and currently has more than 1,200 people who work together in four global research centers. In 2021,...
Grifols is a publicly traded Catalan pharmaceutical company. The company's activity is focused on the research, development, manufacturing, and marketing of plasma-derived products (blood products), intravenous...
Grifols has lost around 70% of its market value since the start of the pandemic. In the eyes of investors, its main burdens are debt, which...
The six listed pharmaceutical companies closed the first quarter with a stock market value of €9.5 billion, compared to €10.6 billion at the close of the...
Grifols will reduce the workforce of its industrial plasma business in the United States, its core business, affecting 2,000 workers by 2023. In addition, in corporate...
Janssen increased its profit to €72.2 million last year. In total, Johnson&Johnson expects year-end revenue to be between $93 billion and $93.5 billion, while it expects...
Reig Jofre reported a profit of €4.2 million between January and September 2022, 16% less than in the same period of 2021. The company justifies this...
The service, also known as AlphaID At Home, is Grifols' first FDA-cleared service for direct-to-consumer use. It will be available beginning in the second quarter of...
The Catalan pharmaceutical company Grifols reduced its profit by 46% through June, a period in which it earned €144.1 million. In 2021, the pharmaceutical company specializing...